We were able to safely treat macroprolactinemia in our patient during pregnancy with cabergoline. This case report contributes to the relatively meager data available which advocates the safety of cabergoline therapy in pregnant hyperprolactinemic patients.
by H Tang 2024 Cited by 120The use of cabergoline does not affect the pregnancy outcome (clinical pregnancy rate, miscarriage rate), nor is there an increased risk of
by M Ono 2024 Cited by 171This clinical study was undertaken to determine the effi- cacy and safety of cabergoline in pregnancy induction and its lactinoma with cabergoline during
During pregnancy, Cabergoline should be used only when clearly needed. Discuss the risks and benefits with your doctor. It is unknown if Cabergoline passes into breast milk. However, Cabergoline may affect breast milk production. Breast-feeding while using Cabergoline is not recommended. Consult your doctor before breast-feeding.
pregnancy of 156 patients with polycystic ovary syndrome Dostinex, cabergoline, kabergolina. ZOSTAW ODPOWIEDŹ Anuluj odpowiedź.
Hyperprolactinemia is one of the causes of sterility. Cabergoline is indicated in cases resistant to bromocriptine, but, usually, its administration is interrupted at the beginning of the pregnancy. A case of prolonged treatment with cabergoline during pregnancy is reported, without teratogenic effe
Pregnancy was significantly more achieved among the women with the treatment of cabergoline (82%) as compared to bromocriptine (56.4%) (P 0.001). Interpretation conclusion: Our results suggest that cabergoline treatment in infertile women with prolactinemia is more effective.
Progesterone is a female hormone in the ovaries responsible for the menstrual cycles and maintaining the pregnancy in a woman. Buspirone. C. Cabergoline
by M Ono 2024 Cited by 171The dose of cabergoline at the first pregnancy was 0.25–9 mg/wk overall and 2–9 mg/wk in the resistant patients. Of the 93 pregnancies achieved on cabergoline
Comments